Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. W. Borgdorff (The Hague, The Netherlands). Can we define latent tuberculosis infection?. Annual Congress 2003 - Latent tuberculosis infection - preventive approaches

Member's Comments

No comment yet.

Related content which might interest you: How should we treat latent tuberculosis infection? Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches Year: 2003 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007 Different genetics background of patients with latent tuberculosis infection versus active tuberculosis Source: International Congress 2017 – Asthma genetics and genomics in patients and populations Year: 2017 Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 The dynamics of tuberculosis incidence and diagnostics of latent tuberculosis tuberculosis infection in children of Ukraine. Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people Year: 2018 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018 Latent tuberculosis infection as a cause of tuberculosis disease Source: Eur Respir J 2003; 22: Suppl. 45, 157s Year: 2003 Completion of treatment for latent tuberculosis infection Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Immunological differences between lung tuberculosis and latent tuberculosis infection Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Latent tuberculosis infection: a new paradigm Source: International Congress 2019 – State of the art session: Respiratory infections Year: 2019 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection Source: Eur Respir J 2010; 36: 135-142 Year: 2010 The set of immunological tests for detection of active tuberculosis in children with latent infection Source: International Congress 2019 – Paediatric tuberculosis Year: 2019 Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Screening migrants for tuberculosis and latent TB infection: the reward will come later Source: Eur Respir J, 54 (4) 1901719; 10.1183/13993003.01719-2019 Year: 2019 Identification of high risk factors for development of active tuberculosis in children with latent tuberculosis infections Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Expression of the PDCD1 gene to determine active tuberculosis infection in children and adolescents with latent TB infection Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis Year: 2020 Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1238-1239 Year: 2011